Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1641 1677 1678 1681
This examiner grants 75% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17959315 | METHOD FOR GENERATING A MARKER IN A BIOLOGICAL SAMPLE | Non-Final OA | Leica Microsystems CMS GmbH |
| 17912713 | POINT-OF-CARE DIGITAL MICROFLUIDICS FOR SEPSIS DIAGNOSIS | Final Rejection | Mayo Foundation for Medical Education and Research |
| 18349015 | Methods and Systems for Determining Kinetic Parameters | Non-Final OA | Genentech, Inc. |
| 18079556 | METHOD FOR DETECTING ANTIGEN-SPECIFIC ACTIVATED T CELL | Non-Final OA | SYSMEX CORPORATION |
| 17799164 | MONITORING VIABILITY OF ORGANS FOR TRANSPLANTATION | Non-Final OA | The General Hospital Corporation |
| 18111571 | Method for removing protein corona of the surface of nanometer particle | Non-Final OA | ZHEJIANG UNIVERSITY |
| 18094221 | T CELL SPECIFIC BIOMARKERS FOR PREDICTING GRAFT-VS-HOST DISEASE AND HEMATOPOIETIC MALIGNANCY RELAPSE FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION AND TREATMENT THEREOF | Non-Final OA | Wisconsin Alumni Research Foundation |
| 18018209 | TEST REAGENT WITH AMELIORATED SIGNAL REDUCTION | Non-Final OA | Denka Company Limited |
| 18039132 | Methods and Compositions Utilising Vitamin B12 Binding | Non-Final OA | Quadram Institute Bioscience |
| 18112142 | MICROSCOPIC DETECTION OF BLAST-TRANSFORMED MONONUCLEAR CELLS | Non-Final OA | IMMUNOGENETICS.COM, INC. |
| 17928829 | METHOD FOR EVALUATING EFFICACY OF ANTICANCER DRUG OR SCREENING ANTICANCER DRUG | Non-Final OA | ORGANOIDSCIENCES LTD. |
| 17761489 | AN IN VITRO KIT AND A METHOD FOR DIAGNOSTICS IN TRANSPLANTS AND/OR AUTOIMMUNE DISEASES AND/OR TUMOR DISEASES AND/OR VACCINATIONS AND A MESSENGER-SUBSTANCE-CONTAINING SUPERNATANT, CELL-CONTAINING SEDIMENT, AND A COMBINATION, FOR USE IN DIAGNOSTICS IN TRANSPLANTS AND/OR AUTOIMMUNE DISEASES AND/OR TUMOR DISEASES AND/OR VACCINATIONS | Non-Final OA | HOT Screen GmbH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy